Trop-2 in Upper Tract Urothelial Carcinoma

Trop-2 in Upper Tract Urothelial Carcinoma

Trophoblast cell surface antigen 2 (Trop-2, encoded by <i>TACSTD2</i>) is the target protein of sacituzumab govitecan, a novel antibody-drug conjugate for locally advanced or metastatic urothelial carcinoma. However, the expression status of Trop-2 in upper tract urothelial carcinoma (UT...

Full description

Bibliographic Details
Main Authors: Eisuke Tomiyama, Kazutoshi Fujita, Kosuke Nakano, Ken Kuwahara, Takafumi Minami, Taigo Kato, Koji Hatano, Atsunari Kawashima, Motohide Uemura, Tetsuya Takao, Hiroaki Fushimi, Kotoe Katayama, Seiya Imoto, Kazuhiro Yoshimura, Ryoichi Imamura, Hirotsugu Uemura, Norio Nonomura
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Current Oncology
Subjects:
trophoblast cell surface antigen 2
<i>TACSTD2</i>
upper tract urothelial carcinoma
immunohistochemical analysis
RNA sequencing
sacituzumab govitecan
Online Access:https://www.mdpi.com/1718-7729/29/6/312

Internet

https://www.mdpi.com/1718-7729/29/6/312

Similar Items